scorecardresearch
Add as a preferred source on Google
Monday, June 1, 2026
TopicDengue

Topic: Dengue

Google wants to kill disease-causing mosquitoes. Their weapon of choice is more mosquitoes

Alphabet Inc’s life sciences wing, Verily, has been breeding 'good' mosquitoes for the past 10 years under its Debug programme. It's finally ready to release them in the US.

India’s first dengue vaccine has been in the making for 17 yrs. DengiAll has the world excited

At the Panacea Biotec office, conversations around DengiAll are cloaked with an air of eagerness. With the human trials enrollment ending with over 10,000 participants, the company is waiting for approval.

How Serum Institute, DNDi tie-up for affordable antibody will bolster global fight against dengue

There is no specific medicine for dengue yet. If ongoing Phase III trials yield positive results, an effective, affordable & specific antiviral would be available, 'ultimately saving more lives'. 

Dengue fever outbreak grips the world. 5 ways to stop it

Over four billion people are currently at risk from mosquito-borne infections, including dengue, Zika, and chikungunya. It's estimated to rise to five billion by 2050.

India may soon get 1st dengue vaccine, but wait for jab effective against all 4 strains could be longer

With govt's local clinical trials waiver for certain drugs and vaccines, Japanese firm Takeda may soon launch QDenga, which will be a boost for India’s fight against dengue.

India sees alarming rise in dengue cases even before peak season, steady increase over past 4 years

Most number of cases in southern states, Maharashtra. Experts stress need for policy & community action, say global warming may have contributed to proliferation of source mosquitoes.

Covid antibodies making dengue more severe, suggests study by govt-run institute

This preprint study is 1st to demonstrate anti-SARS-CoV-2 antibodies can cross-react with dengue virus serotype and enhance its infection through antibody-dependent enhancement.

Japan firm Takeda’s dengue vaccine gets WHO panel backing, but no nod yet for phase 3 trials in India

Takeda's QDENGA, designed to protect against all 4 dengue virus serotypes, has been recommended by Strategic Advisory Group of Experts on Immunization for use in endemic countries.

Top Reasons Why Dengue Cases Are Getting More Severe

Dengue fever, caused by the Aedes mosquito, has long been a concern in tropical and subtropical regions, including parts of Asia, Latin America, and the Caribbean.

Vaccine manufacturer Indian Immunologicals Ltd to launch dengue vaccine by January 2026

According to NCDC, there was a 333% surge in dengue cases from 2020 to 2021 and a 21% rise in number of cases between 2021 and 2022.

On Camera

Growth, inflation & the gaps in between: What latest RBI annual report says about where India stands

RBI's Annual Report necessitates acknowledgement of an economy that not only withstood one of most challenging external environments in recent history but also experienced acceleration.

India revives plan to acquire small submarines. Foreign design or indigenous solution is the question

EXCLUSIVE | Indian Navy has reinitiated discussions with at least 2 Indian shipyards for procurement of vessels, meant for covert missions by the force's elite Marine Commandos.

2026 is like 1973 Indira-era oil shock plus youth anger. Modi has space, but not immunity

An oil shock, monsoon fears, rampant unemployment, and the seeming inevitability of inflation are common to both eras. Indira Gandhi’s self-destructive responses are instructive today.